Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ADLAI-NORTYE-LTD-158339361/news/Adlai-Nortye-Announces-Completion-of-Patient-Enrollment-in-Global-Phase-III-Clinical-Trial-of-Buparl-45384643/?utm_source=whatsapp&utm_medium=social&utm_campaign=share